Biological and Pharmaceutical Bulletin
The Pharmaceutical Society of Japan, established in 1880, is one of Japan’s oldest and most distinguished academic societies. The Society currently has around 18,000 members. It publishes three monthly scientific journals. Chemical and Pharmaceutical Bulletin (Chem. Pharm. Bull.) began publication in 1953 as Pharmaceutical Bulletin. It covers chemistry fields in the pharmaceutical and health sciences. Biological and Pharmaceutical Bulletin (Biol. Pharm. Bull.) began publication in 1978 as the Journal of Pharmacobio-Dynamics. It covers various biological topics in the pharmaceutical and health sciences. A fourth Society journal, the Journal of Health Science, was merged with Biol. Pharm. Bull. in 2012. Yakugaku Zasshi (Japanese for “Pharmaceutical Science Journal”) has the longest history, with publication beginning in 1881. Yakugaku Zasshi is published mostly in Japanese, except for some articles related to clinical pharmacy and pharmaceutical education, which are published in English.
The main aim of the Society’s journals is to advance the pharmaceutical sciences with research reports, information exchange, and high-quality discussion. The average review time for articles submitted to the journals is around one month for first decision. The complete texts of all of the Society’s journals can be freely accessed through J-STAGE. The Society’s editorial committee hopes that the content of its journals will be useful to your research, and also invites you to submit your own work to the journals.

Chairman of Committee
Ken-ichi Hosoya
Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama

Read more
9,639 registered articles
(updated on November 16, 2018)
Online ISSN : 1347-5215
Print ISSN : 0918-6158
Featured article
Volume 41 (2018) Issue 11 Pages 1716-1721
Analysis of Glycoforms and Amino Acids in Infliximab and a Biosimilar Product Using New Method with LC/TOF-MS Read more
Editor’s picks

How can you know the structural difference between biosimilar and reference product? The structure of biosimilar products is not the same as their original product because of post-translational modifications. In the article by Tsuda et al., a valuable method with a papain digestion and LC/TOF-MS analysis was established. Their new method can analyze not only carbohydrate chains but also amino acids of bio-medicines including biosimilar antibodies. This technology will provide a useful strategy to evaluate bio-medicines including biosimilar antibodies.

View the past featured articles
Most viewed articles Oct.2018
Share this page
Select past volume & issue
Journal news & Announcements
  • Biol. Pharm. Bull. Vol. 41 No. 10
    Current Topics: Transporter Research Yields New Discoveries in Life Sciences
  • Biol. Pharm. Bull. Vol. 41 No. 9
    Current Topics: Recent Advances in Research on Biological Membranes That Regulate the Central Nervous System

  • Biol. Pharm. Bull. Vol. 41 No. 8
    Current Topics: Ion Channels as Therapeutic Targets for the Immune, Inflammatory, and Metabolic Disorders

  • Biol. Pharm. Bull. Vol. 41 No. 7
    Current Topics:New Insights into Neurozinc and Metallothioneins

  • Biol. Pharm. Bull. Vol. 41 No. 3
    Current Topics: Cutting-Edge Studies Using Artificial Membranes